PT  - JOURNAL ARTICLE
AU  - S. Cekic
AU  - Y. Karali
AU  - S.S. Kilic
TI  - AB1121 Evaluation of cases diagnosed with crmo; single centre experience
AID  - 10.1136/annrheumdis-2018-eular.3104
DP  - 2018 Jun 01
TA  - Annals of the Rheumatic Diseases
PG  - 1666--1667
VI  - 77
IP  - Suppl 2
4099  - http://ard.bmj.com/content/77/Suppl_2/1666.3.short
4100  - http://ard.bmj.com/content/77/Suppl_2/1666.3.full
SO  - Ann Rheum Dis2018 Jun 01; 77
AB  - Background Chronic recurrent multifocal osteomyelitis (CRMO); is a rare autoinflammatory bone disease characterised by recurrent, sterile inflammatory lesions occurring primarily in children and adolescents. Symptoms of presentation may range from mild unspecific bone pain, local swelling and warmth to severe pain, malaise, fevers and even fractures.Objectives In this study, we aimed to evaluate our patients who had a diagnosis of CRMO, retrospectively.Methods Six patients who were diagnosed with CRMO between 2010–2017 years were included in the study. The CRMO diagnosis was based on characteristic clinical features and magnetic resonance imaging findings. The clinical data were obtained from the records of electronic files.Results The female to male ratio of the cases was 4/2 and the median age was 11.15 years.6–12 The age of diagnosis was 10.35 years (4–12.5), the median period for diagnosis delay was 3 years (0.75–8). The most common complaint was localised pain (n=6, 100%). Accompanying diseases were detected in 3 patients; 1 case had inflammatory myositis, 1 case had PFAPA syndrome and 1 case had selective IgA deficiency. Multifocal bone involvement was present in 4 (66%) cases and unifocal bone involvement in 2 (33%) cases. The most common site of disease was femur. Acute phase reactants were high most of the cases; elevated erythrocyte sedimentation rate (ESR) in 5 cases (83.3, n=6), elevated c-reactive protein level in 4 cases (66.6%, n=6), elevated serum amyloid a level in 3 cases (60%, n=5), and elevated fibrinogen in 2 cases (50%, n=4) were present. ANA was found positive at low titer in only 1 case, whereas rheumatoid factor was negative in all cases. Non-steroidal anti-inflammatory drugs were prescribed in all cases and anti TNF drugs in 3 (Etanercept in 2 cases and adalimumab in 1 case). Clinical characteristics of the patients are given in Table 1.View this table:Abstract AB1121 – Table 1 Clinical findings of the casesConclusions The diagnosis of CRMO is difficult and no consensus exist on diagnosis and treatment. Multifocal bone lesions with characteristic radiological findings are very suggestive of CNO. The first line treatment is usually NSAIDs, however, anti TNF treatment are needed in some patients to achieve for remission. Our case is the second one who had inflammatory myositis and CRMO according the literature.Disclosure of Interest None declared